Safely Prescribing GLP-1 Medications for Older Adults: Remote care solutions that offer protection and connection
Remote care solutions, like connected devices and remote patient monitoring allow for safer GLP-1 use in older adults.
Part 3: Supporting Safe and Sustainable Weight Loss With GLP-1s – Managing weight after medication
Weight gain is likely when patients stop taking a GLP-1 therapy. A 2022 study found patients who took the GLP-1 semaglutide had regained two thirds of their prior weight and had similar cardiometabolic changes a year after stopping the medication. Prescribers at doctor’s offices and virtual weight loss programs should track patients throughout their journey and when they stop taking GLP-1s. This monitoring of daily progress provides long-term oversight of weight loss goals and maintenance.
Part 1: Supporting Safe and Sustainable Weight Loss With GLP-1s – Finding the right remote health technologies
New medications like GLP-1 agonists offer a promising tool to help patients achieve a healthy weight. But supporting patients in long-term weight loss involves more than medication.